InsiderClue
Insiders · Profile

Garren Hideki

Chief Medical Officer at PROTHENA CORP PUBLIC · Director at Coya Therapeutics. Filing since 6 Jul 2022. CIK 0001854126

PRTA PROTHENA CORP PUBLIC LTD CO Chief Medical Officer · 12 trades COYA Coya Therapeutics, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
PRTA PROTHENA CORP PUBLIC LTD CO
13 Sep 2023
Chief Medical Officer
Sold on a plan
2,000
$110.95K
100%
PRTA PROTHENA CORP PUBLIC LTD CO
16 Aug 2023
Chief Medical Officer
Sold on a plan
2,000
$117.48K
100%
PRTA PROTHENA CORP PUBLIC LTD CO
12 Jul 2023
Chief Medical Officer
Sold on a plan
2,000
$135.03K
100%
PRTA PROTHENA CORP PUBLIC LTD CO
16 Jun 2023
Chief Medical Officer
Sold on a plan
7,331
$542.49K
100%
PRTA PROTHENA CORP PUBLIC LTD CO
14 Jun 2023
Chief Medical Officer
Sold on a plan
4,669
$346.52K
100%
PRTA PROTHENA CORP PUBLIC LTD CO
15 Mar 2023
Chief Medical Officer
Sold, plan not stated
12,000
$580.94K
100%
COYA Coya Therapeutics, Inc.
3 Jan 2023
Director
Bought
2,000
no price
opened
PRTA PROTHENA CORP PUBLIC LTD CO
1 Dec 2022
Chief Medical Officer
Sold, plan not stated
4,000
$250.04K
100%
PRTA PROTHENA CORP PUBLIC LTD CO
1 Nov 2022
Chief Medical Officer
Sold, plan not stated
4,000
$247.57K
100%
PRTA PROTHENA CORP PUBLIC LTD CO
3 Oct 2022
Chief Medical Officer
Sold, plan not stated
4,000
$243.60K
100%
PRTA PROTHENA CORP PUBLIC LTD CO
15 Sep 2022
Chief Medical Officer
Sold, plan not stated
4,000
$120.00K
100%
PRTA PROTHENA CORP PUBLIC LTD CO
1 Aug 2022
Chief Medical Officer
Sold, plan not stated
4,000
$122.08K
100%
PRTA PROTHENA CORP PUBLIC LTD CO
6 Jul 2022
Chief Medical Officer
Sold, plan not stated
8,000
$240.00K
100%
13 decisions on file.